Operators may place on the market the following derived products:

1. (a)

   cosmetic products as defined in F1Article 2(1)(a) of Regulation 1223/2009/EC;

2. (b)

   active implantable medical devices as defined in Article 1(2)(c) of Directive 90/385/EEC;

3. (c)

   medical devices as defined in Article 1(2)(a) of Directive 93/42/EEC;

4. (d)

   in vitro diagnostic medical devices as defined in Article 1(2)(b) of Directive 98/79/EC;

5. (e)

   veterinary medicinal products as defined in Article 1(2) of Directive 2001/82/EC;

6. (f)

   medicinal products as defined in Article 1(2) of Directive 2001/83/EC.